FcRL5 Lentivirus

Catalog #
78715
$1,005 *
Size: 500 µl x 2
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The FcRL5 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human FcRL5 (NM_031281.3) driven by an EF1A promoter and a puromycin selection marker (Figure 1).

Figure 1: Schematic of the lenti-vector used to generate the FcRL5 Lentivirus.

Synonyms
Fc receptor-like protein 5, FcR-like protein 5, FcRL5, BXMAS1, Fc receptor homolog 5 (FcRH5), Immune receptor translocation-associated protein 2, CD307e, FCRL5, FCRH5, IRTA2, UNQ503/PRO820
Product Info
Storage and Usage
Citations
Supplied As
Two vials (500 µl x 2) of lentivirus at a titer ≥106 TU/ml. The titer will vary with each lot; the exact value is provided with each shipment.
Formulation

The lentivirus particles were produced from HEK293T cells. They are supplied in cell culture medium containing 90% DMEM + 10% FBS.

UniProt #
Q96RD9
Background

FcRL5 (Fc receptor-like protein 5) is a single-pass transmembrane protein containing 8 immunoglobulin-like C2-type domains in its extracellular portion, and a short cytoplasmic tail. FcRL5 is expressed in B cells and may be involved in B cell development and lymphomagenesis. Moreover, it is enriched in malignant plasma cells of patients diagnosed with multiple myeloma and is an attractive target for antibody-drug conjugates (ADC) and anti-FcRL5 CAR T cells.